2m 2m 2m 2m 2m 2m 2m
Valion Bio (VBIO)
NASDAQ
$0.12-$0.004 (-2.94%)
Price as of Aug 21, 2026 7:59 PM EDT- $508,944.00Market Cap
- N/A1-Year Change
- BiotechnologyIndustry
Valion Bio (VBIO)
$0.12-$0.004 (-2.94%)
VBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.12 | ||
Change | +$0.0005 (+0.41%) | ||
Open | $0.12 | ||
High | $0.13 | ||
Low | $0.11 | ||
Previous Close | $0.12 | ||
Volume | 3,906,050 | ||
30-Day Average Volume | 17,870,775 | ||
1-Week Change | -35.68% | ||
1-Month Change | -60.58% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.2M | ||
Total Assets | $32.5M | ||
Market Cap | $508,944.00 | ||
Enterprise Value | $5.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$7.1M | ||
Free Cash Flow | -$5.3M | ||
EBIT | -$6.4M | ||
EBITDA | -$6.1M | ||
Net Working Capital | $336,000.00 | ||
EPS | -$2.17 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue